Phyllis Zee, MD, PhD, GME ’87, has received the Lifetime Achievement Award from the National Sleep Foundation for her contributions to sleep medicine and the public health mission of the foundation.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
Shi-Yuan Cheng, PhD, professor in The Ken and Ruth Davee Department of Neurology in the Division of Neuro-oncology, has been named a fellow of the American Association for the Advancement of Science (AAAS) for his outstanding contributions to molecular and translational cancer research.
Tanya Simuni, MD, director of the Parkinson’s Disease and Movement Disorders Center, has received a multimillion-dollar grant from The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression for use in clinical trials for novel therapies.
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
Northwestern Medicine scientists have developed a novel cell lineage tracing method that can better determine the origin of mammalian neuron populations from progenitor cells.
Phyllis Zee, MD, PhD, GME ’87, the Benjamin and Virginia T. Boshes Professor of Neurology, has been awarded the Sleep Research Society’s 2020 Distinguished Scientist Award for her significant contributions to sleep and circadian research.